Literature DB >> 22175275

Substance P derivatives as versatile tools for specific delivery of various types of biomolecular cargo.

Shahir S Rizk1, Agnieszka Misiura, Marcin Paduch, Anthony A Kossiakoff.   

Abstract

The use of proteins or nucleic acids as therapeutic agents has been severely hampered by their intrinsic inability to cross the cell membrane. Moreover, common techniques for driving the delivery of macromolecules lack the ability to distinguish between healthy and diseased tissue, precluding their clinical use. Recently, receptor-mediated delivery (RMD) has emerged as a technology with the potential to circumvent the obstacles associated with the delivery of drug targets by utilizing the natural endocytosis of a ligand upon binding to its receptor. Here, we describe the synthesis of variants of substance P (SP), an eleven amino acid neuropeptide ligand of the neurokinin type 1 receptor (NK1R), for the delivery of various types of cargo. The variants of SP were synthesized with an N-terminal maleimide moiety that allows conjugation to surface thiols, resulting in a nonreducible thioether. Cargos lacking an available thiol are conjugated to SP using commercially available cross-linkers. In addition to the delivery of proteins, we expand the use of SP to include nuclear delivery of DNA fragments that are actively expressed in the target cells. We also show that SP can be used to deliver whole bacteriophage particles as well as polystyrene beads up to 1 μm in diameter. The results show the ability of SP to deliver cargo of various sizes and chemical properties that retain their function within the cell. Furthermore, the overexpression of the NK1R in many tumors provides the potential for developing targeted delivery reagents that are specific toward diseased tissue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175275      PMCID: PMC3268364          DOI: 10.1021/bc200496e

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  22 in total

1.  Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells.

Authors:  P D Kassner; M A Burg; A Baird; D Larocca
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

Review 2.  Targeted toxins in pain.

Authors:  Ronald G Wiley; Douglas A Lappi
Journal:  Adv Drug Deliv Rev       Date:  2003-08-28       Impact factor: 15.470

3.  Stable expression of high affinity NK1 (substance P) and NK2 (neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells.

Authors:  U Gether; T Marray; T W Schwartz; T E Johansen
Journal:  FEBS Lett       Date:  1992-01-27       Impact factor: 4.124

4.  Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.

Authors:  Brian Dalby; Sharon Cates; Adam Harris; Elise C Ohki; Mary L Tilkins; Paul J Price; Valentina C Ciccarone
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

5.  Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

Authors:  P W Mantyh; S D Rogers; P Honore; B J Allen; J R Ghilardi; J Li; R S Daughters; D A Lappi; R G Wiley; D A Simone
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

6.  Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA.

Authors:  Jian-Ping Lai; Steven D Douglas; Yan-Jian Wang; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

Review 7.  The role of tachykinins via NK1 receptors in progression of human gliomas.

Authors:  C Palma; C A Maggi
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

8.  Time-course of the internalization and recycling of neurokinin 1 receptors in rat dorsal horn neurons.

Authors:  Xueren Wang; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2002-07-19       Impact factor: 3.252

Review 9.  Cystic fibrosis, vector-mediated gene therapy, and relevance of toll-like receptors: a review of problems, progress, and possibilities.

Authors:  Timothy J Atkinson
Journal:  Curr Gene Ther       Date:  2008-06       Impact factor: 4.391

10.  A novel receptor-targeted gene delivery system for cancer gene therapy.

Authors:  P Tian; S Ren; C Ren; Q Teng; S Qu; M Yao; J Gu
Journal:  Sci China C Life Sci       Date:  1999-04
View more
  3 in total

Review 1.  Getting across the cell membrane: an overview for small molecules, peptides, and proteins.

Authors:  Nicole J Yang; Marlon J Hinner
Journal:  Methods Mol Biol       Date:  2015

2.  Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure-Activity Relationships.

Authors:  Joanna Matalińska; Katarzyna Kosińska; Paweł K Halik; Przemysław Koźmiński; Piotr F J Lipiński; Ewa Gniazdowska; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

3.  Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.

Authors:  Yun-Mi Jeong; Xian Wu Cheng; Kyung Hye Lee; Sora Lee; Haneul Cho; Weon Kim
Journal:  BMC Mol Cell Biol       Date:  2020-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.